About-cancer/treatment/drugs/everolimus/zh

依维莫司

该页面包含有关依维莫司的简要信息，以及一些链接的集合，这些链接指向有关该药物的使用，研究结果和正在进行的临床试验的更多信息。

美国品牌名称

Afinitor

Afinitor Disperz

Zortress

FDA批准

是

该药物的FDA标签信息可从DailyMed获得。

用于癌症

依维莫司被批准用于治疗：

• 乳腺癌. 它与依西美坦联合用于绝经后患有晚期激素受体阳性（HR +）乳腺癌且HER2阴性（HER2-）的女性，经来曲唑或阿那曲唑治疗后并未好转。

• Pancreatic cancer, gastrointestinal cancer, and lung cancer (certain types). It is used in adults with progressive neuroendocrine tumors that cannot be removed by surgery, are locally advanced, or have metastasized (spread to other parts of the body).

• Renal cell carcinoma (a type of kidney cancer) that is advanced, in adults who have not gotten better after treatment with sunitinib or sorafenib.

• Subependymal giant cell astrocytoma in adults and children aged 1 year or older who have tuberous sclerosis and are not able to have surgery.

The use of everolimus to treat cancer is approved for the Afinitor and Afinitor Disperz brands. Everolimus is also approved to treat transplant rejection. This use is approved for the Zortress brand.

Everolimus is also being studied in the treatment of other types of cancer.

More About Everolimus

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

MedlinePlus Information on Everolimus - A lay language summary of important information about this drug that may include the following:

• warnings about this drug,

• what this drug is used for and how it is used,

• what you should tell your doctor before using this drug,

• what you should know about this drug before using it,

• other drugs that may interact with this drug, and

• possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Research Results and Related Resources

Targeted Cancer Therapies

Combination Therapy Shows Promise for Treating Advanced Breast Cancer

Targeted Therapies May Be Effective Against Rare Pancreatic Cancer

Clinical Trials Accepting Patients

Find Clinical Trials for Everolimus - Check for trials from NCI's list of cancer clinical trials now accepting patients.

Important: The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.